This manual provides practical guidance on the selection of molecular WHO-recommended rapid diagnostic (mWRD) and drug resistance tests for TB and drug-resistant TB. It is designed to be suitable for use in any country, with a customizable approach that assists users to tailor their selection efforts based on their local context. The document includes a stepwise approach to selection of one or more mWRDs and a decision pathway to follow. It also includes a description of all mWRDs recommended by WHO as of December 2021, as well as key considerations and questions to ask when making a final mWRD selection to best meet patient and program needs.
